Individualized Homoeopathic Medicines Alleviated the Recurrent Epistaxis in Identical Twins with Severe von Willebrand Disease and Haemophilia A: A Duo Case Report.

Homoeopathy in vWD

  • Kumat O Communication Consultant, Homoeopathy In Haemophilia – Amravati, Nagpur, Dhule, Sambhaji Nagar Centre And Assistant Professor, Physiology Department, Smt. K. B. Abad Homoeopathy Medical College and Hospital, Chandwad, Nashik, Maharashtra, India https://orcid.org/0000-0003-0156-998X
  • Kundu T Principal Investigator, Homoeopathy In Haemophilia, c/o Sakha The Centre of Research and Charity, Upnagar, Nashik, Maharashtra, India And Prof. & HOD of Medicine, Motiwala (National) Homoeopathic, Medical College, Nashik, Maharashtra, India https://orcid.org/0000-0002-3380-3059
  • Kalda P Research Associate, Homoeopathy In Haemophilia https://orcid.org/0000-0001-9881-6582
  • Aswar C Principal, Prof. & HOD of Physiology and Biochemistry, Takhatmal Shrivallabh Homoeopathic College and Hospital, Rajapeth, Amravati, Maharashtra, India
Keywords: von Willebrand Disease, Individualized Homoeopathic Medicine, Identical Twins, Haemophilia A, Epistaxis

Abstract

Background: von Willebrand Disease (vWD) is an inherited genetic bleeding disorder that prevents the blood from clotting. Prevalence of vWD is estimated to be approximately 1% of the population (or 10,000 cases per million population). The vWF binds and stabilizes blood clotting factor (FVIII) in circulation and therefore it helps in clot formation.

Case Profiles: This duo case report is the classical example of association of vWD with haemophilia A in identical twins, where both the patients shared the same disease pattern and manifestations like recurrent epistaxis & ecchymotic patches. But when it came to homoeopathic prescription both of them were prescribed 2 different constitutional medicines on the basis of their behavior, constitution, etc.

Result & Discussion: ISTH-BAT (International Society on Thrombosis and Haemostasis-Bleeding Assessment Tool) scale was used to measure the frequency of epistaxis and bruises which reduced from 6 to 1 in the elder twin and from 7 to 4 in the younger one. Modified Naranjo Criteria in Homoeopathy was used to assess the homoeopathic result with the score of 10 for the elder twin and 8 for the younger twin. This Duo Case Report signifies the role of two different Individualized Homoeopathic Medicines in the identical twins though sharing the similar disease pattern.       

Conclusion: Homoeopathic medicines prescribed on the basis of individualization alleviated the genetic disease symptoms and improved the quality of life of the patients’ and the family members.

Downloads

Download data is not yet available.

Author Biographies

Kumat O, Communication Consultant, Homoeopathy In Haemophilia – Amravati, Nagpur, Dhule, Sambhaji Nagar Centre And Assistant Professor, Physiology Department, Smt. K. B. Abad Homoeopathy Medical College and Hospital, Chandwad, Nashik, Maharashtra, India
  • Communication Consultant, Homoeopathy In Haemophilia.
  • Assistant Professor of Physiology Department, Smt. K. B. Abad Homoeopathic Medical College and Hospital, Chandwad, Nashik, Maharashtra, India
Kundu T, Principal Investigator, Homoeopathy In Haemophilia, c/o Sakha The Centre of Research and Charity, Upnagar, Nashik, Maharashtra, India And Prof. & HOD of Medicine, Motiwala (National) Homoeopathic, Medical College, Nashik, Maharashtra, India
  • Principal Investigator, Homoeopathy In Haemophilia, c/o Sakha The Centre of Research and Charity, Upnagar, Nashik, Maharashtra, India
  • Prof. & HOD of Medicine, Motiwala (National) Homoeopathic, Medical College, Nashik, Maharashtra, India.
Kalda P, Research Associate, Homoeopathy In Haemophilia
  • Research Associate, Homoeopathy In Haemophilia.
Aswar C, Principal, Prof. & HOD of Physiology and Biochemistry, Takhatmal Shrivallabh Homoeopathic College and Hospital, Rajapeth, Amravati, Maharashtra, India
  • Principal, Prof. & HOD of Physiology and Biochemistry, Takhatmal Shrivallabh Homoeopathic College and Hospital, Rajapeth, Amravati, Maharashtra, India.

References

1. Nichols WL, Hultin MB, James AH, Manco‐Johnson MJ, Montgomery RR, Ortel TL, Rick ME, Sadler JE, Weinstein M, Yawn BP. von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1. Haemophilia. 2008 Mar; 14(2):171-232.
2. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease.Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. The Journal of pediatrics. 1993 Dec 1; 123(6):893-8.
3. Castaman, G., Lethagen, S., Federici, A.B., Tosetto, A., Goodeve, A., Budde, U., Batlle, J., Meyer, D., Mazurier, C., Fressinaud, E. and Goudemand, J., 2008. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood, The Journal of the American Society of Hematology, 111(7), pp.3531-3539.
4. Nichols WL, Hultin MB, James AH, MANCO‐JOHNSON MJ, Montgomery RR, Ortel TL, Rick ME, Sadler JE, Weinstein M, Yawn BP. von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1. Haemophilia. 2008 Mar;14(2):171-232.
5. Gitschier J. Genetic basic of hemophilia A. Thromb Haemostas 1991; 66: 37-39
6. Swystun LL, James PD. Genetic diagnosis in hemophilia and von Willebrand disease. Blood Reviews. 2017 Jan 1; 31(1):47-56.
7. Mohl A, Marschalek R, Masszi T, Nagy E, Obser T, Oyen F, Sallai K, Bodo I, Schneppenheim R. An Alu‐mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary. Journal of Thrombosis and Haemostasis. 2008 Oct 1; 6(10):1729-35.
8. Sanders YV, Van der Bom JG, Isaacs A, Cnossen MH, de Maat MP, Laros-van Gorkom BA, Fijnvandraat K, Meijer K, van Duijn CM, Mauser-Bunschoten EP, Eikenboom J. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease. Journal of Thrombosis and Haemostasis. 2015 Jun 1; 13(6):956-66.
9. Zimmerman TS, Ruggeri ZM. Coagulation and Bleeding Disorders: The Role of Factor VIII and von Willebrand Factor. Vol 9. M. Dekker; New York: 1989
10. Seghatchian MJ, Savidge GF. Factor VUI-von Willebrand Factor. Biochemical, Methodological and Functional Aspects. Vol 1. CRC Press; Boca Raton, CA: 1989
11. Nilsson IM. Von Willebrand’s disease from 1926-1983. Scand J Haematol 1984; 40: 21-43
12. Sadler JE, Davie EW, Hemophilia A, hemophilia B. von Willebrand’s disease. In: The molecular basis of blood diseases. W. Saunders; Philadelphia, PA: 1987. pp 575-630
13. Mazurier C. von Willebrand disease masquerading as haemophilia A. Thrombosis and haemostasis. 1992; 67(04):391-6.
14. Kong AW, Zhang D, Lu G. A study of identical twins’ palmprints for personal verification. Pattern Recognition. 2006 Nov 1; 39(11):2149-56.
15. Gray J. Medical Genetics: Principles and Practice. Journal of Medical Genetics. 1995 Feb; 32(2):159.
16. Hahnemann S. Organon of medicine. 6thedn. New Delhi: B. Jain Publication, 1990.
17. Kent JT. Lectures on homoeopathic philosophy. B. Jain publishers; 2003.
18. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D, ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. Journal of Thrombosis and Haemostasis. 2010 Sep; 8(9):2063-5.
19. RADAR (2021) 10.5-open the homeopathic software.
20. Vithoulkas G, Chabanov D. The evolution of miasm theory and its relevance to homeopathic prescribing. Homeopathy. 2022 Oct 28; 112(01):057-64.
21. Mansouritorghabeh H. Consanguineous marriage and rare bleeding disorders. Expert Review of Hematology. 2021 May 4; 14(5):467-72.
22. Vaidyanathan G. Redefining clinical trials: the age of personalized medicine. Cell. 2012 Mar 16; 148(6):1079-80.
23. Khurana A. Research design in Homoeopathy: A perspective. Indian Journal of Research in Homoeopathy. 2019 Oct 1; 13(4):207.
24. Rutten L, Manchanda RK. Homoeopathy: Discussion on scientific validation.
25. Jadhav U, Mukherjee K, Thakur H. Usage of complementary and alternative medicine among severe hemophilia A patients in India. Journal of Evidence-Based Complementary & Alternative Medicine. 2013 Jul;18(3):191-7.
26. Shah R. Symptom similarity versus disease similarity: revisiting the application of the law of similars and challenging the symptom-centric approach in homeopathy. Homeopathy. 2018 Aug; 107(03):218-22.
27. Lamba CD, Gupta VK, van Haselen R, Rutten L, Mahajan N, Molla AM, Singhal R. Evaluation of the modified naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy. 2020 Mar 25;109(04):191-7.
How to Cite
1.
Kumat O, Kundu T, Kalda P, Aswar C. Individualized Homoeopathic Medicines Alleviated the Recurrent Epistaxis in Identical Twins with Severe von Willebrand Disease and Haemophilia A: A Duo Case Report. Int J Med Res Rev [Internet]. 2025Feb.18 [cited 2025Feb.22];13(1):11-8. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/1532
Issue
Vol 13 No 1 (2025): Jan-Mar
Section
Case Report

Copyright (c) 2025 Author (s). Published by Siddharth Health Research and Social Welfare Society

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.